ArticleSpinal cord2026
Cultural adaptation and validation for Brazilian portuguese of the MENTOR tool: monitoring the efficacy of neurogenic bowel treatment.
Article in Spinal cord, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designCross-sectional study of cultural adaptation and validation.
objectivesTo translate and validate the MENTOR Tool, an instrument designed to monitor the effectiveness of treatment for neurogenic bowel dysfunction (NBD) and to support more objective clinical decision-making in individuals with spinal cord injury (SCI).
settingIndividuals with SCI treated at the Anita Garibaldi Health Education and Research Center, Macaiba/RN, and at Oswaldo Cruz University Hospital, Recife/PE, Brazil.
methodsCross-cultural adaptation was conducted at two specialized referral centers for SCI, following the international methodology proposed by Guillemin et al. The MENTOR Tool was administered as an interview and reapplied after an interval of 7 to 21 days. In addition, participants completed the Gastrointestinal Symptom Rating Scale (GSRS). The following measurement properties were evaluated: reproducibility, internal consistency, reliability, and construct validity.
results50 individuals participated in the study. The MENTOR Tool demonstrated excellent reproducibility, with an intraclass correlation coeficiente (ICC) of 0.974, Internal consistency was acceptable, with a Cronbach's alpha of 0.61. Construct Validity was supported by significant correlations between the final Neurogenic Bowel Dysfunction Score (NBDS) and GSRS scores, as well as between GSRS scores and the final MENTOR rating. Additionally, statistically significant differences were observed among the three MENTOR categories.
conclusionsThe MENTOR tool was successfully translated and validated into Brazilian Portuguese, demonstrating reliability and reproducibility for monitoring bowel treatment effectiveness in individuals with SCI and supporting clinical decision-making in the management of NBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.